LCN2 and chronic kidney disease: The estimated association between plasma NGAL and the risk of new-onset CKD (composite outcome) when adjusted for potentially confounding variables (Model 4, Table 2) did not materially change when participants with UAE > 25 mg/24-h (instead of 30 mg/24-h) at baseline were excluded (HR per doubling 1.37 [95% CI: 1.08–1.74], p = 0.011).